CDKN2A and lung cancer: To determine whether the pathway responds to heterozygous oncogenic K-Ras mutation, we measured the expression of Arf in KPRL/F-TAM(-) and KPRL/F-TAM(+) lung cancers, which bear a heterozygous oncogenic K-Ras mutation.